Ibalizumab
Ibalizumab
Latest Posts
-
Ibalizumab, a monoclonal antibody for treating Multidrug resistant HIV infection
A new biologic medication – the first for HIV – is showing promise in treating patients with multidrug resistance, according to phase 3 research being presented at IDWeek 2016™. Administered intravenously once every two weeks, ibalizumab is…
You must be logged in to post a comment.